Dr. Helen L. Baron, MD

Dr. Baron practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Baron's NPI, 1295762995, was assigned on June 27, 2006. Dr. Baron graduated from Keck School of Medicine of USC in 2000. Dr. Baron's California license number on file is A79314.

Dr. Baron's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Baron also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Baron's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. Dr. Baron is also affiliated with Desert Regional Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Baron to 1 more breast imaging center, 1 clinical lab and 1 dialysis center, each named with a free account. Dr. Baron's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baron practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Baron's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Baron is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Baron has a license on file in California.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, hypercalcemia, osteoporosis, overactive thyroid, parathyroid gland disorder and testicular dysfunction among the conditions Dr. Baron treats.

CMS data shows 1,323 Medicare services from Dr. Baron across 4 procedure codes in 2024, for 462 Medicare patients. Medicare paid $77,045 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 462 Medicare patients who saw Dr. Baron in 2024. The largest group is 75 to 84, with 222 patients. 75% of them have diabetes, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baron's median patient age at 76, with 47% women.

In 2024, Dr. Baron wrote 4,041 Medicare Part D claims for 513 patients. 31% of them were for generic drugs. CMS names the drug for 3,772 of them, across 51 drugs with 11 or more claims each, at $2,154,570 in total drug cost. In 2023, CMS named 3,346 claims across 45 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Baron for performance year 2024, reported as part of a group. Dr. Baron accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baron as offering telehealth.

Dmand AI links 4 papers to Dr. Baron, published from 2018 to 2019. Dr. Baron's most frequent co-authors are Hermes J. Florez, MD and Medha N. Munshi, MD.

Dmand AI links Dr. Baron to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus. Open Payments lists research payments to Dr. Baron that name 1 trial.

CMS Open Payments shows 1,879 general payments to Dr. Baron from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Sanofi and Genzyme US Companies paid the most, $1,234,108. It also lists 6 research payments totaling $1,992 from 2017 to 2018, naming 1 clinical trial.

Dr. Baron graduated from Keck School of Medicine of USC in 2000.

Dr. Baron is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.